Impact of frailty on patients with Covid-19 infection [COVID-19]
Research type
Research Study
Full title
What impact does frailty have on patient with confirmed Covid-19 infection?
IRAS ID
286550
Contact name
Laura Hopkins
Contact email
Sponsor organisation
London North West University Healthcare NHS Trust
Duration of Study in the UK
0 years, 5 months, 17 days
Research summary
Frailty is a condition of increased vulnerability to return to previous function following a stressful event e.g. fall, new medications or hospital admission. It is associated with higher risk of acute hospital admission and death. A common tool used to assess frailty is the Rockwood Clinical Frailty Scale (CFS), a pictorial scale from 1-9. A score of > 5 would mean a patient is a high risk of deterioration in function or death; this is likely to be within 6 months with a score of 8 or 9. 7% of the population over 65 years are likely to be severely frail and a population at significant risk of infections including COVID-19.\n\nThe British Geriatric Society (BGS) have published a statement highlighting frailty as an important topic to be studied during this pandemic. We need to understand what the exact impact is on frail older people who contract Covid-19 to better support them in their care, be it in rehabilitation or towards end of life care. Alongside this, we also need to understand what the exact impact is on frail patients who contract Covid-19 to help determine appropriate treatment pathways for them in the future. \n\nNorthwick Park Hospital (NPH) in north west London was one of the earliest epicentres of the COVID-19 outbreak in the UK. We aim to carry out a retrospective observational study to assess the relationship between high frailty scores and outcomes from COVID-19. The primary outcome would be mortality, and secondary outcomes will be length of stay and decline in functional ability.
REC name
N/A
REC reference
N/A